MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2026 International Congress

    Genetically proven Juvenile-Onset Niemann–Pick Disease Type C Presenting with Dystonia- Ataxia syndrome.

    A. Ranjan, A. Kumar, A. -, N. Sinha, A. Kumar, P. Anand (Patna, India)

    Objective: We present a case  Juvenile-Onset Niemann–Pick Disease Type C (NPC) who Presented to us with progressive Dystonia- Ataxia syndrome. Background: Niemann–Pick disease type C…
  • 2026 International Congress

    Temporal Ordering of Biomarker Abnormality Events Leading to Cognitive Impairment in Parkinson’s Disease: A Disease Event-Based Model Analysis of the PPMI Cohort

    A. Negida (Richmond, USA)

    Objective: To estimate the temporal ordering of multimodal biomarker abnormality events leading to cognitive impairment in PD using a Disease Event-Based Model (DEBM), incorporating clinical,…
  • 2026 International Congress

    Does Subthalamic Nucleus DBS Produce Sustained Improvement in Postural Abnormalities? A 5 Year Prospective Study

    M. Siddiqui, R. Shivacharan (Winston Salem, USA)

    Objective: To evaluate the long-term effects of subthalamic nucleus (STN) deep brain stimulation (DBS) on postural abnormalities in patients with advanced Parkinson’s disease (PD). Background:…
  • 2026 International Congress

    Plasma Extracellular Vesicle Protein Biomarker Discovery for Monogenic and Sporadic Dystonia

    Z. Caffall, J. Jordan, A. Norain, L. Longyear, G. Aldykiewicz, T. Tran, A. Wagle-Shukla, N. Sharma, A. Nixon, E. Soderblom, N. Calakos (Durham, USA)

    Objective: To discover plasma biomarkers that differentiate people with dystonia from healthy controls (HC). Background: Blood-based biomarkers for dystonia could address several unmet clinical needs:…
  • 2026 International Congress

    Comparison of Regional Perfusion Patterns in Clinical Subtypes of PSP and CBD: Dual Phase [¹⁸F]FP CIT PET Study

    C. Lee, S. Kim, J. Ko, D. Doudet (Seongnam, Republic of Korea)

    Objective: To investigate the regional perfusion patterns using PET imaging across various clinical subtypes of PSP and CBD. Background: On MRI, PSP typically shows midbrain…
  • 2026 International Congress

    Amyloid status as a moderator of the association between physical activity and progression of Parkinson’s disease

    MJ. Lee, K. Pak, M. Kim, JH. Lee (Busan, Republic of Korea)

    Objective: We investigated a modulation effect of amyloid copathology on the influence of regular physical activity on the progression of Parkinson disease (PD). Background: Physical…
  • 2026 International Congress

    Risk of Ischemic Cerebrovascular Events in Patients with Deep Brain Stimulation for Parkinson’s Disease: A Cohort Study

    P. Antenucci, M. Paciaroni, A. Gozzi, A. Mechelli, M. Pugliatti, D. Gragnaniello, M. Sensi (Ferrara, Italy)

    Objective: To longitudinally assess the risk of ischemic cerebrovascular events in patients undergoing DBS Background: Longitudinal data on the potential impact of DBS on long-term…
  • 2026 International Congress

    Phenotypic Evolution from Nonfluent PPA to PSP

    S. Park (Sejong-si, Republic of Korea)

    Objective: Progressive Supranuclear Palsy (PSP) and Nonfluent Primary Progressive Aphasia (nfvPPA) are clinicopathological entities within the 4-repeat tauopathy (4R tauopathy) spectrum. Increasing evidence suggests that…
  • 2026 International Congress

    MDS Guidance Framework for Electronic Clinical Outcome Assessments: Updating Practices for Validation and Implementation

    R. Fuller, M. Skorvanek, M. Monje, M. Tosin, T. Turner, S. Ali, A. Lane, A. Sanchez Ferro, T. Mestre (Princeton, USA)

    Objective: To present the draft International Parkinson and Movement Disorder Society (MDS) guidance framework for validating, evaluating, and implementing electronic clinical outcome assessments (eCOAs). Background:…
  • 2026 International Congress

    Risk stratification study of fluid biomarkers for alpha-synucleinopathy with dementia

    R. Kamo, A. Okuzumi, H. Takeshige, N. Nishikawa, N. Hattori, T. Hatano (Bunkyo, Japan)

    Objective: This study focuses on mixed pathology of α-synucleinopathy and Alzheimer’s disease(AD), analyzing the relationships among biomarkers, genetic factors, and cognitive function in order to…
  • « Previous Page
  • 1
  • …
  • 203
  • 204
  • 205
  • 206
  • 207
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley